nodes	percent_of_prediction	percent_of_DWPC	metapath
Nisoldipine—CYP1A2—Dacarbazine—sarcoma	0.0737	0.106	CbGbCtD
Nisoldipine—CYP3A7—Vincristine—sarcoma	0.0705	0.101	CbGbCtD
Nisoldipine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0705	0.101	CbGbCtD
Nisoldipine—CYP3A4—Thiotepa—sarcoma	0.0697	0.0999	CbGbCtD
Nisoldipine—ABCB1—Dactinomycin—sarcoma	0.0559	0.0801	CbGbCtD
Nisoldipine—CYP3A5—Vincristine—sarcoma	0.0529	0.0758	CbGbCtD
Nisoldipine—ABCB1—Mitoxantrone—sarcoma	0.05	0.0717	CbGbCtD
Nisoldipine—CYP3A5—Etoposide—sarcoma	0.0485	0.0695	CbGbCtD
Nisoldipine—CYP1A2—Etoposide—sarcoma	0.0361	0.0517	CbGbCtD
Nisoldipine—ABCB1—Vincristine—sarcoma	0.0344	0.0493	CbGbCtD
Nisoldipine—CACNA1S—pes—sarcoma	0.0321	0.418	CbGeAlD
Nisoldipine—ABCB1—Etoposide—sarcoma	0.0315	0.0452	CbGbCtD
Nisoldipine—CYP3A4—Mitoxantrone—sarcoma	0.03	0.043	CbGbCtD
Nisoldipine—ABCB1—Doxorubicin—sarcoma	0.0215	0.0308	CbGbCtD
Nisoldipine—CYP3A4—Vincristine—sarcoma	0.0206	0.0296	CbGbCtD
Nisoldipine—CYP3A4—Etoposide—sarcoma	0.0189	0.0271	CbGbCtD
Nisoldipine—CYP3A4—Doxorubicin—sarcoma	0.0129	0.0185	CbGbCtD
Nisoldipine—CACNA1S—seminal vesicle—sarcoma	0.00391	0.0508	CbGeAlD
Nisoldipine—CACNA2D1—mammary gland—sarcoma	0.00344	0.0448	CbGeAlD
Nisoldipine—CACNA1S—tendon—sarcoma	0.00246	0.032	CbGeAlD
Nisoldipine—CACNA1C—myometrium—sarcoma	0.0021	0.0273	CbGeAlD
Nisoldipine—CACNA1C—connective tissue—sarcoma	0.00173	0.0226	CbGeAlD
Nisoldipine—CACNB2—cardiac atrium—sarcoma	0.00169	0.0221	CbGeAlD
Nisoldipine—CACNA1C—smooth muscle tissue—sarcoma	0.00159	0.0206	CbGeAlD
Nisoldipine—CACNA1D—cardiac atrium—sarcoma	0.00148	0.0193	CbGeAlD
Nisoldipine—CACNB2—tendon—sarcoma	0.00148	0.0192	CbGeAlD
Nisoldipine—CACNA2D1—tendon—sarcoma	0.00139	0.0181	CbGeAlD
Nisoldipine—CACNA1C—cardiac atrium—sarcoma	0.00137	0.0178	CbGeAlD
Nisoldipine—CACNA2D1—bone marrow—sarcoma	0.00134	0.0175	CbGeAlD
Nisoldipine—CYP3A7—liver—sarcoma	0.0013	0.017	CbGeAlD
Nisoldipine—CACNB2—testis—sarcoma	0.00122	0.0159	CbGeAlD
Nisoldipine—CACNB2—liver—sarcoma	0.00116	0.015	CbGeAlD
Nisoldipine—CACNA2D1—testis—sarcoma	0.00115	0.0149	CbGeAlD
Nisoldipine—CYP3A7-CYP3A51P—liver—sarcoma	0.00111	0.0144	CbGeAlD
Nisoldipine—CACNA2D1—liver—sarcoma	0.00109	0.0141	CbGeAlD
Nisoldipine—CACNA1D—testis—sarcoma	0.00107	0.0139	CbGeAlD
Nisoldipine—CACNA1D—liver—sarcoma	0.00101	0.0132	CbGeAlD
Nisoldipine—CACNA1C—testis—sarcoma	0.000987	0.0128	CbGeAlD
Nisoldipine—CYP1A2—hematopoietic system—sarcoma	0.000918	0.012	CbGeAlD
Nisoldipine—CACNB2—lymph node—sarcoma	0.000886	0.0115	CbGeAlD
Nisoldipine—CYP3A5—hematopoietic system—sarcoma	0.000886	0.0115	CbGeAlD
Nisoldipine—CACNA2D1—lymph node—sarcoma	0.000832	0.0108	CbGeAlD
Nisoldipine—CACNA1D—lymph node—sarcoma	0.000775	0.0101	CbGeAlD
Nisoldipine—CACNA1C—lymph node—sarcoma	0.000715	0.00931	CbGeAlD
Nisoldipine—CYP3A4—hematopoietic system—sarcoma	0.000665	0.00865	CbGeAlD
Nisoldipine—ABCB1—myometrium—sarcoma	0.000548	0.00713	CbGeAlD
Nisoldipine—ABCB1—embryo—sarcoma	0.000527	0.00686	CbGeAlD
Nisoldipine—Somnolence—Thiotepa—sarcoma	0.000503	0.00223	CcSEcCtD
Nisoldipine—Oedema—Vincristine—sarcoma	0.000502	0.00222	CcSEcCtD
Nisoldipine—Dyspepsia—Thiotepa—sarcoma	0.000498	0.00221	CcSEcCtD
Nisoldipine—ABCB1—seminal vesicle—sarcoma	0.000495	0.00644	CbGeAlD
Nisoldipine—Increased appetite—Epirubicin—sarcoma	0.000494	0.00219	CcSEcCtD
Nisoldipine—Diabetes mellitus—Doxorubicin—sarcoma	0.000493	0.00219	CcSEcCtD
Nisoldipine—Confusional state—Mitoxantrone—sarcoma	0.000493	0.00218	CcSEcCtD
Nisoldipine—Decreased appetite—Thiotepa—sarcoma	0.000492	0.00218	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Epirubicin—sarcoma	0.000492	0.00218	CcSEcCtD
Nisoldipine—Oedema—Mitoxantrone—sarcoma	0.000489	0.00217	CcSEcCtD
Nisoldipine—Decreased appetite—Dactinomycin—sarcoma	0.000488	0.00216	CcSEcCtD
Nisoldipine—Dysgeusia—Etoposide—sarcoma	0.000488	0.00216	CcSEcCtD
Nisoldipine—Hyperhidrosis—Vincristine—sarcoma	0.000485	0.00215	CcSEcCtD
Nisoldipine—Shock—Mitoxantrone—sarcoma	0.000481	0.00213	CcSEcCtD
Nisoldipine—Muscle spasms—Etoposide—sarcoma	0.000479	0.00212	CcSEcCtD
Nisoldipine—Anorexia—Vincristine—sarcoma	0.000479	0.00212	CcSEcCtD
Nisoldipine—Tachycardia—Mitoxantrone—sarcoma	0.000477	0.00211	CcSEcCtD
Nisoldipine—CYP1A2—liver—sarcoma	0.000476	0.00619	CbGeAlD
Nisoldipine—Cerebrovascular accident—Epirubicin—sarcoma	0.000473	0.0021	CcSEcCtD
Nisoldipine—Cardiac failure congestive—Doxorubicin—sarcoma	0.000473	0.0021	CcSEcCtD
Nisoldipine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000473	0.00209	CcSEcCtD
Nisoldipine—ABCB1—hematopoietic system—sarcoma	0.000471	0.00613	CbGeAlD
Nisoldipine—Hypotension—Vincristine—sarcoma	0.000469	0.00208	CcSEcCtD
Nisoldipine—Feeling abnormal—Thiotepa—sarcoma	0.000467	0.00207	CcSEcCtD
Nisoldipine—Anorexia—Mitoxantrone—sarcoma	0.000466	0.00207	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000464	0.00206	CcSEcCtD
Nisoldipine—Feeling abnormal—Dactinomycin—sarcoma	0.000463	0.00205	CcSEcCtD
Nisoldipine—Ill-defined disorder—Etoposide—sarcoma	0.000462	0.00205	CcSEcCtD
Nisoldipine—Anaemia—Etoposide—sarcoma	0.000461	0.00204	CcSEcCtD
Nisoldipine—CYP3A5—liver—sarcoma	0.000459	0.00597	CbGeAlD
Nisoldipine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000457	0.00203	CcSEcCtD
Nisoldipine—Hypotension—Mitoxantrone—sarcoma	0.000457	0.00202	CcSEcCtD
Nisoldipine—Increased appetite—Doxorubicin—sarcoma	0.000457	0.00202	CcSEcCtD
Nisoldipine—Migraine—Epirubicin—sarcoma	0.000457	0.00202	CcSEcCtD
Nisoldipine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000455	0.00202	CcSEcCtD
Nisoldipine—Insomnia—Vincristine—sarcoma	0.000454	0.00201	CcSEcCtD
Nisoldipine—Paraesthesia—Vincristine—sarcoma	0.000451	0.002	CcSEcCtD
Nisoldipine—Urticaria—Thiotepa—sarcoma	0.00045	0.00199	CcSEcCtD
Nisoldipine—Malaise—Etoposide—sarcoma	0.000449	0.00199	CcSEcCtD
Nisoldipine—Face oedema—Epirubicin—sarcoma	0.000448	0.00198	CcSEcCtD
Nisoldipine—Vertigo—Etoposide—sarcoma	0.000448	0.00198	CcSEcCtD
Nisoldipine—Body temperature increased—Thiotepa—sarcoma	0.000448	0.00198	CcSEcCtD
Nisoldipine—Leukopenia—Etoposide—sarcoma	0.000446	0.00198	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000445	0.00197	CcSEcCtD
Nisoldipine—Body temperature increased—Dactinomycin—sarcoma	0.000444	0.00197	CcSEcCtD
Nisoldipine—Paraesthesia—Mitoxantrone—sarcoma	0.000439	0.00195	CcSEcCtD
Nisoldipine—Loss of consciousness—Etoposide—sarcoma	0.000438	0.00194	CcSEcCtD
Nisoldipine—Cerebrovascular accident—Doxorubicin—sarcoma	0.000438	0.00194	CcSEcCtD
Nisoldipine—Decreased appetite—Vincristine—sarcoma	0.000436	0.00193	CcSEcCtD
Nisoldipine—Ataxia—Epirubicin—sarcoma	0.000436	0.00193	CcSEcCtD
Nisoldipine—Dyspnoea—Mitoxantrone—sarcoma	0.000436	0.00193	CcSEcCtD
Nisoldipine—Cough—Etoposide—sarcoma	0.000435	0.00193	CcSEcCtD
Nisoldipine—Somnolence—Mitoxantrone—sarcoma	0.000435	0.00193	CcSEcCtD
Nisoldipine—Dyspepsia—Mitoxantrone—sarcoma	0.00043	0.00191	CcSEcCtD
Nisoldipine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000429	0.0019	CcSEcCtD
Nisoldipine—Liver function test abnormal—Epirubicin—sarcoma	0.000428	0.0019	CcSEcCtD
Nisoldipine—Dry skin—Epirubicin—sarcoma	0.000425	0.00188	CcSEcCtD
Nisoldipine—Decreased appetite—Mitoxantrone—sarcoma	0.000425	0.00188	CcSEcCtD
Nisoldipine—Chest pain—Etoposide—sarcoma	0.000424	0.00188	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Epirubicin—sarcoma	0.000424	0.00188	CcSEcCtD
Nisoldipine—Migraine—Doxorubicin—sarcoma	0.000422	0.00187	CcSEcCtD
Nisoldipine—Hypokalaemia—Epirubicin—sarcoma	0.000422	0.00187	CcSEcCtD
Nisoldipine—Discomfort—Etoposide—sarcoma	0.000419	0.00186	CcSEcCtD
Nisoldipine—Hypersensitivity—Thiotepa—sarcoma	0.000417	0.00185	CcSEcCtD
Nisoldipine—Face oedema—Doxorubicin—sarcoma	0.000414	0.00184	CcSEcCtD
Nisoldipine—Hypersensitivity—Dactinomycin—sarcoma	0.000414	0.00183	CcSEcCtD
Nisoldipine—Gastritis—Epirubicin—sarcoma	0.000411	0.00182	CcSEcCtD
Nisoldipine—Confusional state—Etoposide—sarcoma	0.00041	0.00182	CcSEcCtD
Nisoldipine—Muscular weakness—Epirubicin—sarcoma	0.000409	0.00181	CcSEcCtD
Nisoldipine—Ataxia—Doxorubicin—sarcoma	0.000404	0.00179	CcSEcCtD
Nisoldipine—Feeling abnormal—Mitoxantrone—sarcoma	0.000403	0.00179	CcSEcCtD
Nisoldipine—Dysphagia—Epirubicin—sarcoma	0.000401	0.00178	CcSEcCtD
Nisoldipine—Influenza—Epirubicin—sarcoma	0.000401	0.00178	CcSEcCtD
Nisoldipine—Asthma—Epirubicin—sarcoma	0.000401	0.00178	CcSEcCtD
Nisoldipine—Pruritus—Thiotepa—sarcoma	0.000401	0.00178	CcSEcCtD
Nisoldipine—Tachycardia—Etoposide—sarcoma	0.000397	0.00176	CcSEcCtD
Nisoldipine—Body temperature increased—Vincristine—sarcoma	0.000397	0.00176	CcSEcCtD
Nisoldipine—Liver function test abnormal—Doxorubicin—sarcoma	0.000396	0.00176	CcSEcCtD
Nisoldipine—Dry skin—Doxorubicin—sarcoma	0.000393	0.00174	CcSEcCtD
Nisoldipine—Hyperhidrosis—Etoposide—sarcoma	0.000393	0.00174	CcSEcCtD
Nisoldipine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000392	0.00174	CcSEcCtD
Nisoldipine—Hypokalaemia—Doxorubicin—sarcoma	0.000391	0.00173	CcSEcCtD
Nisoldipine—Urticaria—Mitoxantrone—sarcoma	0.000388	0.00172	CcSEcCtD
Nisoldipine—Anorexia—Etoposide—sarcoma	0.000388	0.00172	CcSEcCtD
Nisoldipine—Diarrhoea—Thiotepa—sarcoma	0.000387	0.00172	CcSEcCtD
Nisoldipine—Body temperature increased—Mitoxantrone—sarcoma	0.000387	0.00171	CcSEcCtD
Nisoldipine—Diarrhoea—Dactinomycin—sarcoma	0.000384	0.0017	CcSEcCtD
Nisoldipine—Hypotension—Etoposide—sarcoma	0.00038	0.00168	CcSEcCtD
Nisoldipine—Gastritis—Doxorubicin—sarcoma	0.00038	0.00168	CcSEcCtD
Nisoldipine—Muscular weakness—Doxorubicin—sarcoma	0.000379	0.00168	CcSEcCtD
Nisoldipine—Dysuria—Epirubicin—sarcoma	0.000375	0.00166	CcSEcCtD
Nisoldipine—Dizziness—Thiotepa—sarcoma	0.000374	0.00166	CcSEcCtD
Nisoldipine—Influenza—Doxorubicin—sarcoma	0.000371	0.00164	CcSEcCtD
Nisoldipine—Asthma—Doxorubicin—sarcoma	0.000371	0.00164	CcSEcCtD
Nisoldipine—Dysphagia—Doxorubicin—sarcoma	0.000371	0.00164	CcSEcCtD
Nisoldipine—Pollakiuria—Epirubicin—sarcoma	0.00037	0.00164	CcSEcCtD
Nisoldipine—Hypersensitivity—Vincristine—sarcoma	0.00037	0.00164	CcSEcCtD
Nisoldipine—Paraesthesia—Etoposide—sarcoma	0.000365	0.00162	CcSEcCtD
Nisoldipine—Weight increased—Epirubicin—sarcoma	0.000365	0.00162	CcSEcCtD
Nisoldipine—Weight decreased—Epirubicin—sarcoma	0.000363	0.00161	CcSEcCtD
Nisoldipine—Dyspnoea—Etoposide—sarcoma	0.000363	0.00161	CcSEcCtD
Nisoldipine—Somnolence—Etoposide—sarcoma	0.000362	0.0016	CcSEcCtD
Nisoldipine—Hypersensitivity—Mitoxantrone—sarcoma	0.00036	0.0016	CcSEcCtD
Nisoldipine—Rash—Thiotepa—sarcoma	0.000357	0.00158	CcSEcCtD
Nisoldipine—Dermatitis—Thiotepa—sarcoma	0.000357	0.00158	CcSEcCtD
Nisoldipine—ABCB1—uterus—sarcoma	0.000355	0.00463	CbGeAlD
Nisoldipine—Headache—Thiotepa—sarcoma	0.000355	0.00157	CcSEcCtD
Nisoldipine—Rash—Dactinomycin—sarcoma	0.000354	0.00157	CcSEcCtD
Nisoldipine—Decreased appetite—Etoposide—sarcoma	0.000354	0.00157	CcSEcCtD
Nisoldipine—Stomatitis—Epirubicin—sarcoma	0.000348	0.00154	CcSEcCtD
Nisoldipine—Conjunctivitis—Epirubicin—sarcoma	0.000347	0.00154	CcSEcCtD
Nisoldipine—Dysuria—Doxorubicin—sarcoma	0.000347	0.00154	CcSEcCtD
Nisoldipine—CYP3A4—liver—sarcoma	0.000344	0.00448	CbGeAlD
Nisoldipine—Diarrhoea—Vincristine—sarcoma	0.000344	0.00152	CcSEcCtD
Nisoldipine—Sweating—Epirubicin—sarcoma	0.000343	0.00152	CcSEcCtD
Nisoldipine—Pollakiuria—Doxorubicin—sarcoma	0.000343	0.00152	CcSEcCtD
Nisoldipine—Haematuria—Epirubicin—sarcoma	0.000341	0.00151	CcSEcCtD
Nisoldipine—Weight increased—Doxorubicin—sarcoma	0.000338	0.0015	CcSEcCtD
Nisoldipine—Epistaxis—Epirubicin—sarcoma	0.000337	0.00149	CcSEcCtD
Nisoldipine—Nausea—Thiotepa—sarcoma	0.000336	0.00149	CcSEcCtD
Nisoldipine—Weight decreased—Doxorubicin—sarcoma	0.000336	0.00149	CcSEcCtD
Nisoldipine—Sinusitis—Epirubicin—sarcoma	0.000335	0.00149	CcSEcCtD
Nisoldipine—Feeling abnormal—Etoposide—sarcoma	0.000335	0.00149	CcSEcCtD
Nisoldipine—Diarrhoea—Mitoxantrone—sarcoma	0.000335	0.00148	CcSEcCtD
Nisoldipine—Nausea—Dactinomycin—sarcoma	0.000334	0.00148	CcSEcCtD
Nisoldipine—Dizziness—Vincristine—sarcoma	0.000332	0.00147	CcSEcCtD
Nisoldipine—ABCB1—lymphoid tissue—sarcoma	0.000331	0.00431	CbGeAlD
Nisoldipine—Urticaria—Etoposide—sarcoma	0.000323	0.00143	CcSEcCtD
Nisoldipine—Stomatitis—Doxorubicin—sarcoma	0.000322	0.00143	CcSEcCtD
Nisoldipine—Rhinitis—Epirubicin—sarcoma	0.000322	0.00143	CcSEcCtD
Nisoldipine—Body temperature increased—Etoposide—sarcoma	0.000322	0.00142	CcSEcCtD
Nisoldipine—Conjunctivitis—Doxorubicin—sarcoma	0.000321	0.00142	CcSEcCtD
Nisoldipine—Hypoaesthesia—Epirubicin—sarcoma	0.000319	0.00141	CcSEcCtD
Nisoldipine—Pharyngitis—Epirubicin—sarcoma	0.000318	0.00141	CcSEcCtD
Nisoldipine—Sweating—Doxorubicin—sarcoma	0.000317	0.00141	CcSEcCtD
Nisoldipine—Rash—Vincristine—sarcoma	0.000317	0.0014	CcSEcCtD
Nisoldipine—Dermatitis—Vincristine—sarcoma	0.000316	0.0014	CcSEcCtD
Nisoldipine—Oedema peripheral—Epirubicin—sarcoma	0.000316	0.0014	CcSEcCtD
Nisoldipine—Haematuria—Doxorubicin—sarcoma	0.000315	0.0014	CcSEcCtD
Nisoldipine—Headache—Vincristine—sarcoma	0.000315	0.00139	CcSEcCtD
Nisoldipine—Epistaxis—Doxorubicin—sarcoma	0.000312	0.00138	CcSEcCtD
Nisoldipine—Sinusitis—Doxorubicin—sarcoma	0.00031	0.00138	CcSEcCtD
Nisoldipine—Visual impairment—Epirubicin—sarcoma	0.000309	0.00137	CcSEcCtD
Nisoldipine—Rash—Mitoxantrone—sarcoma	0.000308	0.00137	CcSEcCtD
Nisoldipine—Dermatitis—Mitoxantrone—sarcoma	0.000308	0.00136	CcSEcCtD
Nisoldipine—Headache—Mitoxantrone—sarcoma	0.000306	0.00136	CcSEcCtD
Nisoldipine—ABCB1—bone marrow—sarcoma	0.000302	0.00393	CbGeAlD
Nisoldipine—Hypersensitivity—Etoposide—sarcoma	0.0003	0.00133	CcSEcCtD
Nisoldipine—Tinnitus—Epirubicin—sarcoma	0.000299	0.00133	CcSEcCtD
Nisoldipine—Nausea—Vincristine—sarcoma	0.000298	0.00132	CcSEcCtD
Nisoldipine—Rhinitis—Doxorubicin—sarcoma	0.000298	0.00132	CcSEcCtD
Nisoldipine—Hypoaesthesia—Doxorubicin—sarcoma	0.000295	0.00131	CcSEcCtD
Nisoldipine—Pharyngitis—Doxorubicin—sarcoma	0.000295	0.00131	CcSEcCtD
Nisoldipine—Oedema peripheral—Doxorubicin—sarcoma	0.000292	0.0013	CcSEcCtD
Nisoldipine—Nausea—Mitoxantrone—sarcoma	0.00029	0.00129	CcSEcCtD
Nisoldipine—Chills—Epirubicin—sarcoma	0.000288	0.00128	CcSEcCtD
Nisoldipine—Pruritus—Etoposide—sarcoma	0.000288	0.00128	CcSEcCtD
Nisoldipine—Visual impairment—Doxorubicin—sarcoma	0.000286	0.00127	CcSEcCtD
Nisoldipine—Alopecia—Epirubicin—sarcoma	0.000284	0.00126	CcSEcCtD
Nisoldipine—Diarrhoea—Etoposide—sarcoma	0.000278	0.00123	CcSEcCtD
Nisoldipine—Tinnitus—Doxorubicin—sarcoma	0.000277	0.00123	CcSEcCtD
Nisoldipine—Flatulence—Epirubicin—sarcoma	0.000275	0.00122	CcSEcCtD
Nisoldipine—Tension—Epirubicin—sarcoma	0.000274	0.00121	CcSEcCtD
Nisoldipine—Dysgeusia—Epirubicin—sarcoma	0.000274	0.00121	CcSEcCtD
Nisoldipine—Nervousness—Epirubicin—sarcoma	0.000271	0.0012	CcSEcCtD
Nisoldipine—Dizziness—Etoposide—sarcoma	0.000269	0.00119	CcSEcCtD
Nisoldipine—Muscle spasms—Epirubicin—sarcoma	0.000269	0.00119	CcSEcCtD
Nisoldipine—Chills—Doxorubicin—sarcoma	0.000266	0.00118	CcSEcCtD
Nisoldipine—Alopecia—Doxorubicin—sarcoma	0.000262	0.00116	CcSEcCtD
Nisoldipine—Ill-defined disorder—Epirubicin—sarcoma	0.000259	0.00115	CcSEcCtD
Nisoldipine—Anaemia—Epirubicin—sarcoma	0.000258	0.00114	CcSEcCtD
Nisoldipine—ABCB1—testis—sarcoma	0.000258	0.00336	CbGeAlD
Nisoldipine—Rash—Etoposide—sarcoma	0.000256	0.00114	CcSEcCtD
Nisoldipine—Dermatitis—Etoposide—sarcoma	0.000256	0.00114	CcSEcCtD
Nisoldipine—Headache—Etoposide—sarcoma	0.000255	0.00113	CcSEcCtD
Nisoldipine—Flatulence—Doxorubicin—sarcoma	0.000255	0.00113	CcSEcCtD
Nisoldipine—Tension—Doxorubicin—sarcoma	0.000254	0.00112	CcSEcCtD
Nisoldipine—Dysgeusia—Doxorubicin—sarcoma	0.000253	0.00112	CcSEcCtD
Nisoldipine—Malaise—Epirubicin—sarcoma	0.000252	0.00112	CcSEcCtD
Nisoldipine—Nervousness—Doxorubicin—sarcoma	0.000251	0.00111	CcSEcCtD
Nisoldipine—Vertigo—Epirubicin—sarcoma	0.000251	0.00111	CcSEcCtD
Nisoldipine—Syncope—Epirubicin—sarcoma	0.000251	0.00111	CcSEcCtD
Nisoldipine—Leukopenia—Epirubicin—sarcoma	0.00025	0.00111	CcSEcCtD
Nisoldipine—Muscle spasms—Doxorubicin—sarcoma	0.000248	0.0011	CcSEcCtD
Nisoldipine—Palpitations—Epirubicin—sarcoma	0.000247	0.00109	CcSEcCtD
Nisoldipine—Loss of consciousness—Epirubicin—sarcoma	0.000246	0.00109	CcSEcCtD
Nisoldipine—ABCB1—liver—sarcoma	0.000244	0.00317	CbGeAlD
Nisoldipine—Cough—Epirubicin—sarcoma	0.000244	0.00108	CcSEcCtD
Nisoldipine—Nausea—Etoposide—sarcoma	0.000242	0.00107	CcSEcCtD
Nisoldipine—Ill-defined disorder—Doxorubicin—sarcoma	0.00024	0.00106	CcSEcCtD
Nisoldipine—Anaemia—Doxorubicin—sarcoma	0.000239	0.00106	CcSEcCtD
Nisoldipine—Myalgia—Epirubicin—sarcoma	0.000238	0.00105	CcSEcCtD
Nisoldipine—Arthralgia—Epirubicin—sarcoma	0.000238	0.00105	CcSEcCtD
Nisoldipine—Chest pain—Epirubicin—sarcoma	0.000238	0.00105	CcSEcCtD
Nisoldipine—Anxiety—Epirubicin—sarcoma	0.000237	0.00105	CcSEcCtD
Nisoldipine—Discomfort—Epirubicin—sarcoma	0.000235	0.00104	CcSEcCtD
Nisoldipine—Malaise—Doxorubicin—sarcoma	0.000233	0.00103	CcSEcCtD
Nisoldipine—Dry mouth—Epirubicin—sarcoma	0.000233	0.00103	CcSEcCtD
Nisoldipine—Vertigo—Doxorubicin—sarcoma	0.000232	0.00103	CcSEcCtD
Nisoldipine—Syncope—Doxorubicin—sarcoma	0.000232	0.00103	CcSEcCtD
Nisoldipine—Leukopenia—Doxorubicin—sarcoma	0.000231	0.00103	CcSEcCtD
Nisoldipine—Confusional state—Epirubicin—sarcoma	0.00023	0.00102	CcSEcCtD
Nisoldipine—Palpitations—Doxorubicin—sarcoma	0.000228	0.00101	CcSEcCtD
Nisoldipine—Oedema—Epirubicin—sarcoma	0.000228	0.00101	CcSEcCtD
Nisoldipine—Loss of consciousness—Doxorubicin—sarcoma	0.000227	0.00101	CcSEcCtD
Nisoldipine—Cough—Doxorubicin—sarcoma	0.000226	0.000999	CcSEcCtD
Nisoldipine—Shock—Epirubicin—sarcoma	0.000224	0.000994	CcSEcCtD
Nisoldipine—Tachycardia—Epirubicin—sarcoma	0.000223	0.000986	CcSEcCtD
Nisoldipine—Hyperhidrosis—Epirubicin—sarcoma	0.00022	0.000977	CcSEcCtD
Nisoldipine—Chest pain—Doxorubicin—sarcoma	0.00022	0.000975	CcSEcCtD
Nisoldipine—Arthralgia—Doxorubicin—sarcoma	0.00022	0.000975	CcSEcCtD
Nisoldipine—Myalgia—Doxorubicin—sarcoma	0.00022	0.000975	CcSEcCtD
Nisoldipine—Anxiety—Doxorubicin—sarcoma	0.000219	0.000972	CcSEcCtD
Nisoldipine—Discomfort—Doxorubicin—sarcoma	0.000217	0.000963	CcSEcCtD
Nisoldipine—Anorexia—Epirubicin—sarcoma	0.000217	0.000963	CcSEcCtD
Nisoldipine—Dry mouth—Doxorubicin—sarcoma	0.000215	0.000954	CcSEcCtD
Nisoldipine—Hypotension—Epirubicin—sarcoma	0.000213	0.000944	CcSEcCtD
Nisoldipine—Confusional state—Doxorubicin—sarcoma	0.000213	0.000943	CcSEcCtD
Nisoldipine—Oedema—Doxorubicin—sarcoma	0.000211	0.000935	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000208	0.00092	CcSEcCtD
Nisoldipine—Shock—Doxorubicin—sarcoma	0.000208	0.00092	CcSEcCtD
Nisoldipine—Insomnia—Epirubicin—sarcoma	0.000206	0.000914	CcSEcCtD
Nisoldipine—Tachycardia—Doxorubicin—sarcoma	0.000206	0.000912	CcSEcCtD
Nisoldipine—Paraesthesia—Epirubicin—sarcoma	0.000205	0.000907	CcSEcCtD
Nisoldipine—Hyperhidrosis—Doxorubicin—sarcoma	0.000204	0.000904	CcSEcCtD
Nisoldipine—Dyspnoea—Epirubicin—sarcoma	0.000203	0.000901	CcSEcCtD
Nisoldipine—Somnolence—Epirubicin—sarcoma	0.000203	0.000898	CcSEcCtD
Nisoldipine—Anorexia—Doxorubicin—sarcoma	0.000201	0.000891	CcSEcCtD
Nisoldipine—Dyspepsia—Epirubicin—sarcoma	0.000201	0.000889	CcSEcCtD
Nisoldipine—Decreased appetite—Epirubicin—sarcoma	0.000198	0.000878	CcSEcCtD
Nisoldipine—Hypotension—Doxorubicin—sarcoma	0.000197	0.000873	CcSEcCtD
Nisoldipine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000192	0.000852	CcSEcCtD
Nisoldipine—Insomnia—Doxorubicin—sarcoma	0.000191	0.000845	CcSEcCtD
Nisoldipine—Paraesthesia—Doxorubicin—sarcoma	0.000189	0.000839	CcSEcCtD
Nisoldipine—Dyspnoea—Doxorubicin—sarcoma	0.000188	0.000833	CcSEcCtD
Nisoldipine—Feeling abnormal—Epirubicin—sarcoma	0.000188	0.000833	CcSEcCtD
Nisoldipine—Somnolence—Doxorubicin—sarcoma	0.000188	0.000831	CcSEcCtD
Nisoldipine—ABCB1—lymph node—sarcoma	0.000187	0.00243	CbGeAlD
Nisoldipine—Dyspepsia—Doxorubicin—sarcoma	0.000186	0.000823	CcSEcCtD
Nisoldipine—Decreased appetite—Doxorubicin—sarcoma	0.000183	0.000813	CcSEcCtD
Nisoldipine—Urticaria—Epirubicin—sarcoma	0.000181	0.000803	CcSEcCtD
Nisoldipine—Body temperature increased—Epirubicin—sarcoma	0.00018	0.000799	CcSEcCtD
Nisoldipine—Feeling abnormal—Doxorubicin—sarcoma	0.000174	0.00077	CcSEcCtD
Nisoldipine—Hypersensitivity—Epirubicin—sarcoma	0.000168	0.000744	CcSEcCtD
Nisoldipine—Urticaria—Doxorubicin—sarcoma	0.000168	0.000743	CcSEcCtD
Nisoldipine—Body temperature increased—Doxorubicin—sarcoma	0.000167	0.000739	CcSEcCtD
Nisoldipine—Pruritus—Epirubicin—sarcoma	0.000161	0.000715	CcSEcCtD
Nisoldipine—Diarrhoea—Epirubicin—sarcoma	0.000156	0.000691	CcSEcCtD
Nisoldipine—Hypersensitivity—Doxorubicin—sarcoma	0.000155	0.000689	CcSEcCtD
Nisoldipine—Dizziness—Epirubicin—sarcoma	0.000151	0.000668	CcSEcCtD
Nisoldipine—Pruritus—Doxorubicin—sarcoma	0.000149	0.000661	CcSEcCtD
Nisoldipine—Diarrhoea—Doxorubicin—sarcoma	0.000144	0.00064	CcSEcCtD
Nisoldipine—Rash—Epirubicin—sarcoma	0.000144	0.000637	CcSEcCtD
Nisoldipine—Dermatitis—Epirubicin—sarcoma	0.000144	0.000636	CcSEcCtD
Nisoldipine—Headache—Epirubicin—sarcoma	0.000143	0.000633	CcSEcCtD
Nisoldipine—Dizziness—Doxorubicin—sarcoma	0.000139	0.000618	CcSEcCtD
Nisoldipine—Nausea—Epirubicin—sarcoma	0.000135	0.0006	CcSEcCtD
Nisoldipine—Rash—Doxorubicin—sarcoma	0.000133	0.000589	CcSEcCtD
Nisoldipine—Dermatitis—Doxorubicin—sarcoma	0.000133	0.000589	CcSEcCtD
Nisoldipine—Headache—Doxorubicin—sarcoma	0.000132	0.000586	CcSEcCtD
Nisoldipine—Nausea—Doxorubicin—sarcoma	0.000125	0.000555	CcSEcCtD
